Next-generation sequencing and high DNA input identify previously missed measurable residual disease in peripheral

Sonja Bendig1,2, Sandra Bufe1, Michaela Kotrova1

  • 1Medical Department II, Hematology/Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.

Abstract

No abstract available in PubMed .

Related Concept Videos